课题基金 / 基金详情

Regulation of Gene Expression by DNA Binding Ligands

Regulation of Gene Expression by DNA Binding Ligands
DNA 结合配体对基因表达的调节
批准号:
6618628
负责人:
Peter B Dervan
金额:
$45.35万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 2007-03-31

项目摘要

项目成果

Peter B Dervan的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):序列特异性DNA结合小分子,可以渗透到人类细胞中,可能潜在地调节特定基因的转录。在一个人类基因组已被绘制和测序,生物学和人类医学领域已揭示许多人类疾病与异常基因表达有关的时代,DNA结合配体的基础研究可能导致功能基因组学试剂,并可能产生一类新的人类治疗方法。我们的目标是阐明设计小分子的化学原理,这些小分子结合预定的DNA序列,具有转录因子(TF)的亲和力和特异性。聚酰胺可以抑制TF在启动子中的结合,抑制(和激活)无细胞系统中的特定基因表达,并结合凝聚的DNA、染色质。合成聚酰胺已被证明可以抑制原代人t细胞中的病毒基因表达,并调节复杂生物体(果蝇)表型的增益(和损失)。关于具体目标:(1)一类新的聚酰胺结合转运蛋白肽增强核摄取将被探索,以扩大允许核摄取的细胞类型(人类,酵母,果蝇)的库;(2)由连接肽激活域的聚酰胺组成的人工转录激活剂将在细胞培养中被研究;(3)聚酰胺结合HDAC抑制剂将被用来调节转录;(4)一类新的聚酰胺插入物将用于阐明MEF2转录因子在间期染色质基质相关区域的作用;(5)抑制逆转录病毒整合酶的聚酰胺将在细胞培养中进行测试;(6)聚酰胺将用于研究宿主细胞在静息CD4+淋巴细胞中调节HIV潜伏期的分子机制;(7)聚酰胺-氯霉素偶联物将用于NB4人细胞靶向PML启动子。聚酰胺将用于控制活斑马鱼胚胎的基因表达和发育。
英文摘要
DESCRIPTION (provided by applicant): Sequence specific DNA binding small molecules that can permeate human cells could potentially regulate transcription of specific genes. In an era when the human genome has been mapped and sequenced and the fields of biology and human medicine have revealed that many human diseases are linked to aberrant gene expression, fundamental research in DNA binding ligands could lead to reagents for functional genomics and possibly a new class of human therapeutics. Our objective has been to elucidate chemical principles for the design of small molecules which bind predetermined DNA sequences with the affinity and specificity of transcription factors (TF). Polyamides can inhibit binding of TF in promoters, inhibit (and activate) specific gene expression in cell-free systems and bind condensed DNA, chromatin. Synthetic polyamides have been shown to inhibit viral gene expression in primary human T-cells, and to modulate gain (and loss) of phenotype in a complex organism (Drosophila). With regard to specific aims: (1) a new class of polyamides conjugated to transporter peptides for enhanced nuclear uptake will be explored to broaden the repertoire of cell types (human, yeast, Drosophila) which allow nuclear uptake, (2) artificial transcriptional activators comprised of polyamide linked to peptide activation domains will be studied in cell culture, (3) polyamides conjugated to HDAC inhibitors will be used to modulate transcription, (4) a new class of polyamide-intercalators will be used to elucidate the role of MEF2 transcription factor in the matrix associated region in interphase chromatin, (5) polyamides which inhibit retroviral integrase will be tested in cell culture, (6) polyamides will be used to study the host cell molecular mechanism that regulates HIV latency in resting CD4+ lymphocytes, (7) polyamides-chlorambucil conjugates will be used in NB4 human cells to target the PML promoter, and (8) polyamides will be used to control gene expression and development in living zebrafish embryos.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transcription therapeutics for myotonic dystrophy type 1
  • 批准号:
    8822685
  • 项目类别:
  • 资助金额:
    $48.1万
  • 财政年份:
    2014
  • 负责人:
    Peter B Dervan
  • 依托单位:
DERVAN 12-2 PRT
  • 批准号:
    8362344
  • 项目类别:
  • 资助金额:
    $0.11万
  • 财政年份:
    2011
  • 负责人:
    Peter B Dervan
  • 依托单位:
DERVAN 12-2 PRT
  • 批准号:
    8170349
  • 项目类别:
  • 资助金额:
    $0.1万
  • 财政年份:
    2010
  • 负责人:
    Peter B Dervan
  • 依托单位:
Gene Suppression: Drug Target Validation
  • 批准号:
    6582487
  • 项目类别:
  • 资助金额:
    $0.5万
  • 财政年份:
    2003
  • 负责人:
    Peter B Dervan
  • 依托单位:
海外基金